Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1968 1
1969 8
1970 6
1971 2
1972 2
1973 2
1974 3
1975 1
1976 1
1977 1
1978 2
1979 3
1980 5
1981 6
1982 10
1983 10
1984 12
1985 10
1986 13
1987 18
1988 13
1989 10
1990 10
1991 5
1992 6
1993 11
1994 7
1995 8
1996 12
1997 11
1998 7
1999 10
2000 11
2001 8
2002 18
2003 20
2004 22
2005 27
2006 39
2007 30
2008 44
2009 31
2010 40
2011 42
2012 53
2013 49
2014 47
2015 35
2016 39
2017 38
2018 31
2019 37
2020 43
2021 52
2022 54
2023 38
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

986 results

Results by year

Filters applied: . Clear all
Page 1
Author's reply.
Miyazaki Y, Yamagata K, Ishibashi K, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kusano K. Miyazaki Y, et al. Among authors: nagase s. J Cardiol. 2022 Oct;80(4):373-374. doi: 10.1016/j.jjcc.2022.06.004. Epub 2022 Jun 22. J Cardiol. 2022. PMID: 35750556 Free article. No abstract available.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: nagase s. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Free PMC article. Clinical Trial.
Clinical statistics of gynecologic cancers in Japan.
Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Aoki D, Katabuchi H. Yamagami W, et al. Among authors: nagase s. J Gynecol Oncol. 2017 Mar;28(2):e32. doi: 10.3802/jgo.2017.28.e32. Epub 2017 Feb 10. J Gynecol Oncol. 2017. PMID: 28198168 Free PMC article. Review.
Recent advances in claudin-targeting technology.
Nagase S, Doyama R, Yagi K, Kondoh M. Nagase S, et al. Biol Pharm Bull. 2013;36(5):708-14. doi: 10.1248/bpb.b13-00014. Biol Pharm Bull. 2013. PMID: 23649330 Free article. Review.
Time for enhancing government-led primary prevention of cervical cancer.
Min KJ, Suh DH, Baba T, Chen X, Kim JW, Kobayashi Y, Kwon J, Lim MC, Lee JY, Nagase S, Park JY, Tangjitgamol S, Watari H. Min KJ, et al. Among authors: nagase s. J Gynecol Oncol. 2021 Jan;32(1):e12. doi: 10.3802/jgo.2021.32.e12. Epub 2020 Dec 11. J Gynecol Oncol. 2021. PMID: 33327045 Free PMC article. No abstract available.
[The new era of epithelium-targeted drug development].
Shimizu Y, Nagase S, Yagi K, Kondoh M. Shimizu Y, et al. Among authors: nagase s. Yakugaku Zasshi. 2014;134(5):641-5. doi: 10.1248/yakushi.14-00006-5. Yakugaku Zasshi. 2014. PMID: 24790047 Free article. Review. Japanese.
986 results